Pertinence of microsampling in various nonclinical and clinical studies: the ICH perspective

References

• 1. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. ICH harmonised tripartite guideline photosafety evaluation of pharmaceuticals S10, Current Step 4 version (2013). https://database.ich.org/sites/default/files/S10_Guideline.pdf
  Google Scholar
• 2. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. ICH harmonised tripartite guideline note for guidance on toxicokinetics: the assessment of systemic exposure in toxicity studies S3A, Current Step 4 version (1994). https://database.ich.org/sites/default/files/S3A_Guideline.pdf
  Google Scholar
• 3. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. ICH harmonised guideline questions and answers to ICH S3A: note for guidance on toxicokinetics: the assessment of systemic exposure in toxicity studies focus on microsampling S3A Q&As, Final version (2017). https://database.ich.org/sites/default/files/S3A_Q%26As_Q%26As.pdf
  Google Scholar
• 4. Londhe V, Rajadhyaksha M. Opportunities and obstacles for microsampling techniques in bioanalysis: special focus on DBS and VAMS. J. Pharm. Biomed. Anal. 182, 113102 (2020).
  Medline CASGoogle Scholar
• 5. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. ICH harmonised guideline bioanalytical method validation and study sample analysis M10, final version (2022). https://database.ich.org/sites/default/files/M10_Guideline_Step4_2022_0524.pdf
  Google Scholar
• 6. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. ICH harmonised guideline guideline on genomic sampling and management of genomic data E18, current step 4 version (2017). https://database.ich.org/sites/default/files/E18_Guideline.pdf
  Google Scholar
• 7. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. ICH harmonised guideline addendum to ICH E11: clinical investigation of medicinal products in the pediatric population E11 (R1), final version (2017). https://database.ich.org/sites/default/files/E11_R1_Addendum.pdf
  Google Scholar
• 8. Sparrow SS, Robinson S, Bolam S et al. Opportunities to minimise animal use in pharmaceutical regulatory general toxicology: a cross-company review. Regul. Toxicol. Pharmacol. 61(2), 222–229 (2011).
  MedlineGoogle Scholar
• 9. Patel SR, Bryan P, Spooner N, Timmerman P, Wickremsinhe E. Microsampling for quantitative bioanalysis, an industry update: output from an AAPS/EBF survey. Bioanalysis 11(7), 619–628 (2019).
  CASGoogle Scholar